healthcare organizations continue to wrestle with avoidable costs, preventable errors, and operational inefficiency, all while aspiring to improve their consumer experience, outcomes, and bottom line. meanwhile our economies continue to be challenged by rising healthcare costs attributable to fragmented care and long term conditions, especially diabetes, heart failure, copd, and their co-morbidities. common approaches to address these challenges – rip-and-replace information systems, deploy siloed programs that hope to “manage” high-risk patients, use minimally interconnected systems to coordinate care – have proven exorbitantly expensive, unduly cumbersome, financially unsustainable, and eventually inadequate to achieve desired benefits. lumiradx offers proven solutions to directly address these challenges, and partners with its clients to help achieve better health care, social care, and financial outcomes, an improved consumer experience, and the agility to continue this transformat
Company profile
Ticker
LMDX, LMDXW
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
LMDX stock data
Latest filings (excl ownership)
25-NSE
Exchange delisting
21 Mar 24
6-K
Current report (foreign)
6 Feb 24
6-K
Current report (foreign)
29 Dec 23
6-K
Current report (foreign)
8 Dec 23
6-K
Current report (foreign)
20 Nov 23
6-K
Current report (foreign)
6 Nov 23
6-K
Current report (foreign)
6 Nov 23
6-K
Current report (foreign)
1 Nov 23
6-K
Current report (foreign)
31 Oct 23
6-K
LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal
27 Oct 23
Latest ownership filings
SC 13G/A
PETRICHOR HEALTHCARE CAPITAL MANAGEMENT LP
12 Feb 24
SC 13G/A
Senvest Management, LLC
9 Feb 24
SC 13D/A
UMPHREY WILLARD L
29 Dec 23
SC 13D/A
UMPHREY WILLARD L
26 Dec 23
SC 13D/A
UMPHREY WILLARD L
20 Dec 23
SC 13D/A
SCOTT DAVID
8 Nov 23
SC 13D/A
MCALEER JEROME F
8 Nov 23
SC 13D/A
Zwanziger Ventures LLC
7 Nov 23
SC 13D/A
Morningside Venture Investments Ltd
23 Feb 23
SC 13D
Morningside Venture Investments Ltd
14 Feb 23
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Institutional ownership, Q3 2023
69.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 20 |
Opened positions | 11 |
Closed positions | 29 |
Increased positions | 1 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 1.49 bn |
Total shares | 113.97 mm |
Total puts | 0.00 |
Total calls | 133.37 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Morningside Venture Investments | 54.13 mm | $71.99 mm |
Zwanziger Ventures | 42.03 mm | $60.11 mm |
Petrichor Healthcare Capital Management | 9.65 mm | $0.00 |
CVS CVS Health | 5.35 mm | $1.27 bn |
Senvest Management | 2.07 mm | $60.05 mm |
LMR Partners | 200.60 k | $5.82 mm |
Balyasny Asset Management | 184.28 k | $6.65 mm |
Kim | 125.00 k | $4.51 mm |
Moore Capital Management | 62.50 k | $1.81 mm |
MMCAP International Inc. SPC | 42.98 k | $1.25 mm |